Skip to main content
search
Link to Facebook page
Link to X
Link to YouTube channel
Link to flipboard
Link to RSS
Main navigation
Home
About
About ACSH
Financials
Our Team
Video
Donate
Publications
Media/Contact
Subscribe
Write For Us
Perjeta
email
facebook
twitter
linkedin
pocket
reddit
print
Health News Update: September 29, 2014
The latest in health news: a new cancer drug prolongs life, an FDA-approved device could be key in distinguishing between cognitive impairment and Alzheimer's disease, and why heart attacks may look very different in women
Read more
Clinical trials find that breast cancer drug Perjeta extends survival
Last year, the advisory committee to the FDA
Read more
FDA panel recommends approval for pre-surgery treatment of early-stage breast cancer
Read more
Subscribe to Perjeta
ACSH relies on donors like you. If you enjoy our work, please contribute.
Make your tax-deductible gift today!
DONATE
Popular articles
Vaccines, Autism, and a CDC That Blinked
Going into Surgery? Anxious? Here’s Some Versed. Who Cares?
Has The Lancet Given MAHA the Momentum It Needs?
ChatBots on Trial
A Tale of Two Graphs – Why the Four-Phase Opioid Story Falls Apart
ACSH Podcasts
Podcast: 10 Years Cancer-Free: Dr. Dinerstein’s Harrowing Survival Story
Podcast: TRT—Masculine Cure-All for Aging Men, Or Another Health Fad?
Podcast: Apple Cider Vinegar for Acid Reflux? No.
Podcast: Future Vision—Fighting Blindness with Retinal Implants
Podcast: Has Modern Life Wrecked Our Microbiome (And Our Health)?
More podcasts
Latest from Josh
Going into Surgery? Anxious? Here’s Some Versed. Who Cares?
The Delicious Chocolate Egg Cream: No Egg, No Cream. Some Chemistry
Let's Celebrate National Bidet Day! (With Apologies to ABBA)
Stupid Pennies Are Gone - Finally!
More articles
Latest from Chuck
When the Stars Align: CMS Quality Scores Steer Billions and Bend Care
Unexpected Teen Whisperers - The Family Dog
Has The Lancet Given MAHA the Momentum It Needs?
Connections in an Uncertain Age
More articles